Diagnosis and management of acute alcohol withdrawal

A M Holbrook, R Crowther, A Lotter, C Cheng, D King, A M Holbrook, R Crowther, A Lotter, C Cheng, D King

Abstract

Alcohol abuse produces a considerable burden of illness in the Canadian population. The diagnosis of alcohol dependence and withdrawal can be difficult, particularly in the setting of covert intake or comorbidity. Two validated scales, the CAGE questionnaire to screen for alcohol abuse and dependence and the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale to assess the severity of withdrawal, are valuable tools for clinicians to use on a regular basis. For the treatment of alcohol withdrawal, compelling anecdotal evidence supports the routine administration of thiamine, but not necessarily other vitamins. Phenytoin has not been shown to be superior to placebo for uncomplicated withdrawal seizures. Neuroleptics are not recommended for routine use. Sedation with benzodiazepines guided by the CIWA-Ar results is recommended. There is good evidence that the management of alcohol withdrawal can be improved with the routine use of the CIWA-Ar scale to assess severity, treatment with adequate doses of benzodiazepines and follow-up monitoring of patients in alcohol withdrawal.

References

    1. J Clin Psychopharmacol. 1981 Nov;1(6):382-89
    1. Clin Pharmacol Ther. 1983 Aug;34(2):214-9
    1. Clin Pharmacol Ther. 1983 Dec;34(6):822-6
    1. N Engl J Med. 1985 Oct 10;313(15):951-2
    1. Gen Hosp Psychiatry. 1987 Mar;9(2):135-41
    1. CMAJ. 1988 Jul 15;139(2):113-20
    1. Alcohol Clin Exp Res. 1988 Jun;12(3):360-4
    1. N Engl J Med. 1988 Sep 15;319(11):666-73
    1. Pharmacotherapy. 1989;9(3):131-43
    1. J Gen Intern Med. 1989 Sep-Oct;4(5):432-44
    1. Am J Med. 1989 Dec;87(6):645-8
    1. Br J Addict. 1989 Nov;84(11):1353-7
    1. DICP. 1990 Jun;24(6):601-6
    1. Ann Emerg Med. 1991 May;20(5):520-2
    1. JAMA. 1992 May 20;267(19):2638-44
    1. Am J Emerg Med. 1992 May;10(3):203-7
    1. Health Rep. 1991;3(4):363-70
    1. Addiction. 1993 Nov;88(11):1493-508
    1. Ann Emerg Med. 1994 Mar;23(3):513-8
    1. Ann Med. 1994 Apr;26(2):101-5
    1. JAMA. 1994 Aug 17;272(7):519-23
    1. BMJ. 1994 Oct 8;309(6959):911-8
    1. JAMA. 1994 Dec 14;272(22):1782-7
    1. CMAJ. 1995 Mar 15;152(6):851-9
    1. J Gen Intern Med. 1995 Sep;10(9):479-87
    1. Crit Rev Toxicol. 1995;25(4):347-67
    1. BMJ. 1996 Mar 23;312(7033):731-6
    1. Can Fam Physician. 1996 Apr;42:681-9
    1. Neurology. 1997 Mar;48(3):614-20
    1. JAMA. 1997 Jul 9;278(2):144-51
    1. BMJ. 1997 Jul 26;315(7102):211-6
    1. Can Fam Physician. 1997 Nov;43:1959-62, 1965-7
    1. CMAJ. 1997 Dec 1;157(11):1529-35
    1. CMAJ. 1999 Mar 9;160(5):649-55

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa